180 Life Sciences Corp. [ATNF] Stock trading around $3.17 per share: What’s Next?

180 Life Sciences Corp. [NASDAQ: ATNF] slipped around -0.57 points on Wednesday, while shares priced at $3.17 at the close of the session, down -15.24%. The company report on January 11, 2021 that 180 Life Sciences Corp. to Present at the Biotech Showcase(TM) Digital 2021 Conference.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Menlo Park, California–(Newsfile Corp. – January 11, 2021) – 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the “Company”), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, announced that the Company will present at the Biotech Showcase™ Digital 2021 Conference.

The conference is taking place online between January 11-15 and will feature prerecorded sessions of company presentations. Dr. James Woody, Chief Executive Officer, will provide an overview of the Company and progress in key programs.

180 Life Sciences Corp. stock is now 16.12% up from its year-to-date (YTD) trading value. ATNF Stock saw the intraday high of $3.74 and lowest of $3.15 per share. The company’s 52-week high price is 11.50, which means current price is +31.54% above from all time high which was touched on 01/25/21.

Compared to the average trading volume of 1.14M shares, ATNF reached a trading volume of 1675390 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about 180 Life Sciences Corp. [ATNF]?

The Average True Range (ATR) for 180 Life Sciences Corp. is set at 0.42 The Price to Book ratio for the last quarter was 2.33, with the Price to Cash per share for the same quarter was set at 0.03.

How has ATNF stock performed recently?

180 Life Sciences Corp. [ATNF] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.12. With this latest performance, ATNF shares gained by 14.59% in over the last four-week period, additionally sinking by -71.18% over the last 6 months – not to mention a drop of -68.80% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATNF stock in for the last two-week period is set at 49.32, with the RSI for the last a single of trading hit 47.86, and the three-weeks RSI is set at 46.59 for 180 Life Sciences Corp. [ATNF]. The present Moving Average for the last 50 days of trading for this stock 2.77, while it was recorded at 3.67 for the last single week of trading, and 8.47 for the last 200 days.

180 Life Sciences Corp. [ATNF]: Deeper insight into the fundamentals

When it comes to the capital structure of this company, 180 Life Sciences Corp. [ATNF] has a Total Debt to Total Equity ratio set at 53.51. Additionally, ATNF Total Debt to Total Capital is recorded at 34.86, with Total Debt to Total Assets ending up at 22.89.

180 Life Sciences Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.20 and a Current Ratio set at 0.20.

Insider trade positions for 180 Life Sciences Corp. [ATNF]

There are presently around $5 million, or 11.50% of ATNF stock, in the hands of institutional investors. The top three institutional holders of ATNF stocks are: OXFORD ASSET MANAGEMENT LLP with ownership of 321,799, which is approximately -15.87% of the company’s market cap and around 22.90% of the total institutional ownership; GLAZER CAPITAL, LLC, holding 296,280 shares of the stock with an approximate value of $1.11 million in ATNF stocks shares; and YAKIRA CAPITAL MANAGEMENT, INC., currently with $1.08 million in ATNF stock with ownership of nearly -0.449% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

9 institutional holders increased their position in 180 Life Sciences Corp. [NASDAQ:ATNF] by around 319,971 shares. Additionally, 12 investors decreased positions by around 761,053 shares, while 5 investors held positions by with 461,708 shares. The mentioned changes placed institutional holdings at 1,542,732 shares, according to the latest SEC report filing. ATNF stock had 6 new institutional investments in for a total of 144,410 shares, while 6 institutional investors sold positions of 500,849 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam